Effectiveness of anti-B-cell maturation antigen (BCMA)-targeting therapy after selinexor treatment

被引：0
|
作者：
Baljevic, Muhamed [1 ]
Moreau, Philippe [2 ]
Tuchman, Sascha [3 ]
Callander, Natalie [4 ]
Lentzsch, Suzanne [5 ]
Van Domelen, Dane [6 ]
Bentur, Ohad [6 ]
Monge, Jorge [7 ]
Biran, Noa [8 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[2] Univ Hosp Hotel Dieu, Nantes, France
[3] Univ N Carolina, Chapel Hill Comprehens Canc Ctr, Chapel Hill, NC USA
[4] Univ Wisconsin, Madison, WI USA
[5] Columbia Univ, Med Ctr, New York, NY USA
[6] Karyopharm, Newton, MA USA
[7] Weill Cornell Med, Myeloma Ctr, New York, NY USA
[8] Hackensack Univ, Med Ctr, Hackensack, NJ USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-232
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [31] T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions in Patients with Relapsed Multiple Myeloma
    Mikkilineni, Lekha
    Manasanch, Elisabet E.
    Lam, Norris
    Vanasse, Danielle
    Brudno, Jennifer N.
    Maric, Irina
    Rose, Jeremy J.
    Stetler-Stevenson, Maryalice
    Wang, Hao-Wei
    Yuan, Constance M.
    Stroncek, David F.
    Mann, Jennifer
    Ganadan, Micaela
    Patel, Rashmika
    Trinklein, Nathan
    Buelow, Ben
    Gress, Ronald E.
    Kochenderfer, James N.
    [J]. BLOOD, 2019, 134
  • [32] Engineering an APRIL-specific B-cell maturation antigen (BCMA)
    Patel, DR
    Wallweber, HJ
    Yin, J
    Shriver, SK
    Marsters, SA
    Gordon, NC
    Starovasnik, MA
    Kelley, RF
    [J]. PROTEIN SCIENCE, 2004, 13 : 95 - 95
  • [33] Is Bridging Radiation (RT) Safe with B Cell Maturation Antigen-targeting Chimeric Antigenic Receptor T Cells (CART-BCMA) Therapy?
    Manjunath, S. H.
    Cohen, A. D.
    Arscott, W. T.
    Maity, A.
    Plastaras, J. P.
    Paydar, I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S165 - S166
  • [34] Continuous anti-B-cell therapy: successful adjunct to treatment for ANCA-associated vasculitis
    Rhee, Eugene P.
    Laliberte, Karen A.
    Niles, John L.
    [J]. APMIS, 2009, 117 : 69 - 69
  • [35] In-Situ Protein Expression Analysis of B-Cell Maturation Antigen (BCMA)
    Jungbluth, Achim
    Dogan, Ahmet
    Frosina, Denise
    Fayad, Miriam
    Smith, Eric
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 526 - 526
  • [36] In-Situ Protein Expression Analysis of B-Cell Maturation Antigen (BCMA)
    Jungbluth, Achim
    Dogan, Ahmet
    Frosina, Denise
    Fayad, Miriam
    Smith, Eric
    [J]. MODERN PATHOLOGY, 2018, 31 : 526 - 526
  • [37] Selectivity and specificity of engineered T cells expressing KITE-585, a chimeric antigen receptor targeting B-cell maturation antigen (BCMA)
    Adams, Gregor B.
    Feng, Jun
    Ghogha, Atefeh
    Mardiros, Armen
    Rodriguez, Ruben
    Spindler, Tassja J.
    Wiltzius, Jed
    Polverino, Tony
    [J]. CANCER RESEARCH, 2017, 77
  • [38] SPECIAL ASPECTS OF GLUCOCORTICOID THERAPY IN PATIENTSWHO TREATED WITH ANTI-B-CELL AND ANTI-BLYS THERAPY
    Mesnyankina, Anna
    Solovyev, Sergey
    Aseeva, Elena
    Nasonov, Evgeny
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1702 - 1702
  • [39] Clinical activity of P-BCMA-ALLO1, a B-cell maturation antigen (BCMA) targeted allogeneic chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed refractory multiple myeloma (RRMM) patients (pts) following progression on prior BCMA targeting therapy
    Dholaria, Bhagirathbhai
    Shune, Leyla
    Kin, Andrew
    McArthur, Katherine
    Eskew, Jeff D.
    Martin, Christopher E.
    Haag, Sabrina
    McCaigue, Joanne
    Namini, Hamid
    DePrimo, Sam
    Cranert, Stacey
    Coronella, Julia
    Shedlock, Devon
    Belani, Rajesh
    [J]. CANCER RESEARCH, 2024, 84 (07)
  • [40] Targeting B-cell maturation antigen in multiple myeloma
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    [J]. IMMUNOTHERAPY, 2015, 7 (11) : 1187 - 1199
12345